PERSPECTIVES OF APPLICATION OF RECOMBINANT HUMAN INTERLEUKIN-1 BETA IN TREATMENT OF ACUTE DAMAGES OF STOMACH MUCOSA IN RATS



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

T A Sazonova

State Research Institute Of Highly Pure Biopreparations

E A Varyushina

State Research Institute Of Highly Pure Biopreparations

G V Aleksandrov

State Research Institute Of Highly Pure Biopreparations

G O Gudima

State Research Institute Of Highly Pure Biopreparations

A S Simbirtsev

State Research Institute Of Highly Pure Biopreparations

References

  1. Симбирцев А.С. Биология семейства интерлейкина-1 человека. Иммунология. 1998, № 3, с. 9-17.
  2. Halter F., Hurlimann S., Inauen W. Pathophysiology and Clinical Relevance of Helicobacter pylori. Yhe Yale Journal of biology and medicine. 1992, v. 65, p. 625-638.
  3. Takahashi S., Kobayashi N., Okabe S. Regulation by endogenous interleukin-1 of mRNA expression of healing-related factors in gastric ulcers in rats. J. Pharmacol. Exp. Ther. 1999, v 291, Issue 2, p. 634-641.
  4. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Ann. Rev. Immunol. 2009, v. 27, p. 519-550.
  5. Raines E.W., Dower S.K., Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muskle cells is due to PDGF. Science. 1989, v. 243, p. 393-394.
  6. Долгушина А.И. Оценка клинико-иммунологической эффективности беталейкина при лечении больных язвенной болезнью желудка и двенадцатиперстной кишки. Автореферат диссертации канд. биол. наук. Челябинск, Челяб. гос. мед. академия. 2003, 22 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies